TNFSF13 and neoplasm: The thirteenth member of the tumor necrosis factor superfamily (TNFSF), designated A PRoliferation-Inducing Ligand (APRIL), was first described in 1998 as a molecule with the ability to stimulate tumor cell growth [1].